BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8199825)

  • 21. Time trends for prostate cancer mortality in Brazil and its geographic regions: An age-period-cohort analysis.
    Braga SFM; de Souza MC; Cherchiglia ML
    Cancer Epidemiol; 2017 Oct; 50(Pt A):53-59. PubMed ID: 28810175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate cancer trends in Canada: rising incidence or increased detection?
    Levy IG; Gibbons L; Collins JP; Perkins DG; Mao Y
    CMAJ; 1993 Sep; 149(5):617-24. PubMed ID: 8364818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population mixing and sudden infant death syndrome in England and Wales.
    Bentham G
    Int J Epidemiol; 1994 Jun; 23(3):540-4. PubMed ID: 7960379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in prostate cancer incidence and mortality in a mid-sized Northeastern Brazilian city.
    Lima CA; Silva AM; Kuwano AY; Rangel MR; Macedo-Lima M
    Rev Assoc Med Bras (1992); 2013; 59(1):15-20. PubMed ID: 23440137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate cancer incidence, mortality and survival trends in Estonia, 1995-2014.
    Innos K; Baburin A; Kotsar A; Eiche IE; Lang K
    Scand J Urol; 2017 Dec; 51(6):442-449. PubMed ID: 29092653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The temporal and spatial epidemiology of lip cancer in England and Wales.
    Hindle I; Downer MC; Speight PM
    Community Dent Health; 2000 Sep; 17(3):152-60. PubMed ID: 11108402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How many people will need palliative care in 2040? Past trends, future projections and implications for services.
    Etkind SN; Bone AE; Gomes B; Lovell N; Evans CJ; Higginson IJ; Murtagh FEM
    BMC Med; 2017 May; 15(1):102. PubMed ID: 28514961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing trends in the epidemiology of malignant melanoma: gender differences and their implications for public health.
    Streetly A; Markowe H
    Int J Epidemiol; 1995 Oct; 24(5):897-907. PubMed ID: 8557445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate cancer incidence in Podkarpackie province in 2002-2011.
    Karczmarek-Borowska B; Radziszewska A
    Przegl Epidemiol; 2015; 69(1):65-72, 163-7. PubMed ID: 25862450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling study.
    Yu XQ; Luo Q; Smith DP; Clements MS; Patel MI; O'Connell DL
    PLoS One; 2017; 12(2):e0171013. PubMed ID: 28178275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Years of potential life lost caused by prostate cancer deaths in the United States-Projection from 2004 through 2050.
    Li C; Ekwueme DU
    Cancer Epidemiol; 2010 Aug; 34(4):368-72. PubMed ID: 20510666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Where people die (1974--2030): past trends, future projections and implications for care.
    Gomes B; Higginson IJ
    Palliat Med; 2008 Jan; 22(1):33-41. PubMed ID: 18216075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in UK regional cancer mortality 1991-2007.
    Marshall DC; Webb TE; Hall RA; Salciccioli JD; Ali R; Maruthappu M
    Br J Cancer; 2016 Feb; 114(3):340-7. PubMed ID: 26766741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality Rate and Years of Life Lost Due to Prostate Cancer in Yazd Province, Iran: A 10-year study.
    Mirzaei M; Mirzadeh M; Mirzaei M
    Sultan Qaboos Univ Med J; 2017 Nov; 17(4):e424-e429. PubMed ID: 29372084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The fall in incidence of prostate carcinoma. On the down side of a prostate specific antigen induced peak in incidence--data from the Utah Cancer Registry.
    Stephenson RA; Smart CR; Mineau GP; James BC; Janerich DT; Dibble RL
    Cancer; 1996 Apr; 77(7):1342-8. PubMed ID: 8608513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impending Canadian prostate cancer epidemic.
    Morrison HI; MacNeill IB; Miller D; Levy I; Xie L; Mao Y
    Can J Public Health; 1995; 86(4):274-8. PubMed ID: 7497416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. United Kingdom Association of Cancer Registries.
    Quinn M; Allen E
    BMJ; 1995 Nov; 311(7017):1391-5. PubMed ID: 8520272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries.
    Wong MC; Goggins WB; Wang HH; Fung FD; Leung C; Wong SY; Ng CF; Sung JJ
    Eur Urol; 2016 Nov; 70(5):862-874. PubMed ID: 27289567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in socio-economic inequalities in female mortality, 2001-08. Intercensal estimates for England and Wales.
    Johnson B; Al-Hamad A
    Health Stat Q; 2011; (52):3-32. PubMed ID: 22143593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in cancer mortality in 15 industrialized countries, 1969-1986.
    Hoel DG; Davis DL; Miller AB; Sondik EJ; Swerdlow AJ
    J Natl Cancer Inst; 1992 Mar; 84(5):313-20. PubMed ID: 1738181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.